INT305390

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.37
First Reported 2009
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 3
Disease Relevance 2.24
Pain Relevance 0.49

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell differentiation (NKX2-5) nucleus (NKX2-5) DNA binding (NKX2-5)
transcription factor binding (NKX2-5) cytoplasm (NKX2-5)
NKX2-5 (Homo sapiens)
Pain Link Frequency Relevance Heat
Angina 29 93.28 High High
depression 8 86.16 High High
Bioavailability 3 77.60 Quite High
adenocard 1 64.12 Quite High
imagery 4 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
tolerance 1 5.00 Very Low Very Low Very Low
Visceral pain 1 5.00 Very Low Very Low Very Low
ischemia 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Increased Venous Pressure Under Development 44 100.00 Very High Very High Very High
Stress 16 94.88 High High
Cv General 3 Under Development 21 93.28 High High
Vascular Disease 2 92.76 High High
Coronary Artery Disease 12 87.88 High High
Depression 8 86.16 High High
Congenital Anomalies 1 73.40 Quite High
Pathologic Constriction 3 68.04 Quite High
Cv Unclassified Under Development 9 67.04 Quite High
Thrombocytopenia 2 62.08 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
TableĀ 1 lists the nine CSX definitions, and hence inclusion criteria, obtained from our review of the 57 studies.
Negative_regulation (lists) of CSX
1) Confidence 0.37 Published 2010 Journal Clin Res Cardiol Section Body Doc Link PMC2911526 Disease Relevance 0.75 Pain Relevance 0.20
The use of this additional inclusion criterion resulted in a decrease of the incidence of CSX to 7% in our population.
Negative_regulation (decrease) of CSX
2) Confidence 0.37 Published 2010 Journal Clin Res Cardiol Section Body Doc Link PMC2911526 Disease Relevance 0.78 Pain Relevance 0.22
Regardless of the higher NO levels in CSX, the FMD values were decreased as compared to controls.
Negative_regulation (decreased) of CSX associated with increased venous pressure under development
3) Confidence 0.26 Published 2009 Journal Upsala Journal of Medical Sciences Section Body Doc Link PMC2852773 Disease Relevance 0.71 Pain Relevance 0.07

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox